Rhabdomyolysis Clinical Trial
Official title:
Exercise-induced Collective Rhabdomyolysis
NCT number | NCT03737513 |
Other study ID # | 2018110801 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | September 9, 2018 |
Est. completion date | May 31, 2019 |
Rhabdomyolysis, which is a characteristic occurrence in associated with muscle cell necrosis, develops due to various causes.The investigators herein report a rare case of collective rhabdomyolysis after high intensity resistance training, including 35 teenagers(participants),in which markedly elevated levels of serum creatine kinase (CK) and serum myoglobin were observed. This high intensity resistance trainings is a part of Military Training(MT),which all the middle school students must finish before admission。
Status | Completed |
Enrollment | 35 |
Est. completion date | May 31, 2019 |
Est. primary completion date | May 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Clinical diagnosis of rhabdomyolysis; - Caused by military training; - Informed consent; - Must be able to cooperate with blood test. Exclusion Criteria: - Caused by drugs and other reasons; - No hospitalization event |
Country | Name | City | State |
---|---|---|---|
China | Yueqing Hospital Affiliated to Wenzhou Medical University | Yueqing | Zhejiang |
Lead Sponsor | Collaborator |
---|---|
Haitao Tu | Yueqing Hospital Affiliated to Wenzhou Medical University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | serum creatine kinase; | Change in serum creatine kinase at 3 months | 3 months | |
Primary | serum myoglobin | At the time of discharge | 1 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00241748 -
Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event
|
N/A | |
Not yet recruiting |
NCT02498366 -
Exertional Rhabdomyolysis- Characterization of Prediction Tests for Return to Duty
|
N/A | |
Not yet recruiting |
NCT06429982 -
Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols
|
Phase 1 | |
Active, not recruiting |
NCT06101680 -
RhabdomYolyse in Intensive caRe
|
||
Withdrawn |
NCT02896517 -
Support for the Rhabdomyolysis in an Emergency Department
|
||
Completed |
NCT01467180 -
Myoglobin Removal by High Cut-off CVVHD
|
N/A | |
Recruiting |
NCT01022450 -
Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients
|
N/A | |
Completed |
NCT00391911 -
Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis
|
Phase 2 | |
Withdrawn |
NCT02111018 -
Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis
|
Phase 2 | |
Completed |
NCT04913298 -
Prospective Study for the Application of Cytosorb® in Critically Ill Patients
|
N/A | |
Recruiting |
NCT05146336 -
CytOSorb TreatMent Of Critically Ill PatientS Registry
|
||
Completed |
NCT03986736 -
Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma
|
||
Not yet recruiting |
NCT02518724 -
The Effect of Remote Ischemic Preconditioning on Physical Performance and Exertional Rhabdomyolysis
|
N/A | |
Completed |
NCT02671604 -
Rhabdomyolysis and Robot-assisted Radical Prostatectomy
|
N/A | |
Completed |
NCT00592657 -
Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions
|
N/A | |
Completed |
NCT06338423 -
Use of a Vacuum Mattress During Laparoscopic Sleeve Gastrectomy to Reduce the Concentration of Rhabdomyolysis Markers and Acute Renal Failure
|
N/A | |
Completed |
NCT01976936 -
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
|
Phase 2 | |
Completed |
NCT04118608 -
Rhabdomyolysis - a Study of Patient Characteristics and Laboratory Values to Guide Treatment
|
||
Completed |
NCT01544231 -
Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis
|
N/A | |
Recruiting |
NCT00549029 -
The Association of Genetic Polymorphisms With Statin-Induced Myopathy.
|
N/A |